Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A11779 | 30747091 | Curr Mol Pharmacol | Activation of GLP-1 and Glucagon Receptors Regulates Bile Homeostasis Independent of Thyroid Hormone. | 2019 | Details |
| A11780 | 30746959 | Rev Esp Enferm Dig | Comparative study of overweight and obese patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11781 | 30746789 | Phytother Res | Coadministration of epigallocatechin-3-gallate (EGCG) and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats. | 2019 | Details |
| A11782 | 30746746 | J Cell Biochem | Cell-specific elevation of Runx2 promotes hepatic infiltration of macrophages by upregulating MCP-1 in high-fat diet-induced mice NAFLD. | 2019 | Details |
| A11783 | 30745847 | Int J Biol Sci | Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer. | 2019 | Details |
| A11784 | 30745819 | Int J Biol Sci | Role of Nutrition in the Pathogenesis and Prevention of Non-alcoholic Fatty Liver Disease: Recent Updates. | 2019 | Details |
| A11785 | 30745809 | Int J Med Sci | Non-alcoholic fatty liver disease is associated with low-grade albuminuria in men without diabetes mellitus. | 2019 | Details |
| A11786 | 30745416 | J Pharmacol Exp Ther | RLA8-A New and Highly Effective Quadruple PPAR-α/γ/δ and GPR40 Agonist to Reverse Nonalcoholic Steatohepatitis and Fibrosis. | 2019 | Details |
| A11787 | 30744663 | BMC Res Notes | Regular exposure to non-burning ultraviolet radiation reduces signs of non-alcoholic fatty liver disease in mature adult mice fed a high fat diet: results of a pilot study. | 2019 | Details |
| A11788 | 30744645 | Lipids Health Dis | Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study. | 2019 | Details |
| A11789 | 30744560 | BMC Gastroenterol | Hepatic sonic hedgehog protein expression measured by computer assisted morphometry significantly correlates with features of non-alcoholic steatohepatitis. | 2019 | Details |
| A11790 | 30744124 | Mar Drugs | Inhibitory Effects of Sodium Alginate on Hepatic Steatosis in Mice Induced by a Methionine- and Choline-deficient Diet. | 2019 | Details |
| A11791 | 30743004 | Clin Gastroenterol Hepatol | American Ancestry Is a Risk Factor for Suspected Nonalcoholic Fatty Liver Disease in Hispanic/Latino Adults. | 2019 | Details |
| A11792 | 30740871 | Diabetes Metab Res Rev | Metabolic effects and safety of Roux-en-Y gastric bypass surgery vs. conventional medication in obese Chinese patients with type 2 diabetes. | 2019 | Details |
| A11794 | 30738435 | Lipids Health Dis | Combining I148M and E167K variants to improve risk prediction for nonalcoholic fatty liver disease in Qingdao Han population, China. | 2019 | Details |
| A11795 | 30738135 | Food Chem Toxicol | Permethrin and ivermectin modulate lipid metabolism in steatosis-induced HepG2 hepatocyte. | 2019 | Details |
| A11796 | 30737662 | Inflammation | Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic Steatohepatitis. | 2019 | Details |
| A11797 | 30737251 | J Lipid Res | Ces1d deficiency protects against high-sucrose diet-induced hepatic triacylglycerol accumulation. | 2019 | Details |
| A11798 | 30736329 | Nutrients | Impact of SchisandraChinensis Bee Pollen on Nonalcoholic Fatty Liver Disease and Gut Microbiota in HighFat Diet Induced Obese Mice. | 2019 | Details |
| A11799 | 30735855 | Biochim Biophys Acta Mol Cell Biol Lipids | Group VIA phospholipase A2 deficiency in mice chronically fed with high-fat-diet attenuates hepatic steatosis by correcting a defect of phospholipid remodeling. | 2019 | Details |
| A11800 | 30735854 | Biochim Biophys Acta Mol Cell Biol Lipids | iPla2β deficiency in mice fed with MCD diet does not correct the defect of phospholipid remodeling but attenuates hepatocellular injury via an inhibition of lipid uptake genes. | 2019 | Details |
| A11801 | 30735525 | PLoS One | Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice. | 2019 | Details |
| A11802 | 30735485 | Med Sci Monit | Correlation Between Adiponectin Gene rs1501299 Polymorphism and Nonalcoholic Fatty Liver Disease Susceptibility: A Systematic Review and Meta-Analysis. | 2019 | Details |
| A11803 | 30734333 | Hepatology | Letter to Editor: Role of Pharmacotherapy in Patients With Coexisting Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. | 2019 | Details |
| A11804 | 30733187 | Dig Liver Dis | Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity? | 2019 | Details |
| A11805 | 30732664 | Proc Nutr Soc | Understanding susceptibility and targeting treatment in non-alcoholic fatty liver disease in children; moving the fulcrum. | 2019 | Details |
| A11806 | 30732555 | Eur J Sport Sci | Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation. | 2019 | Details |
| A11807 | 30732129 | Medicine (Baltimore) | Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11808 | 30731283 | Atherosclerosis | Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps. | 2019 | Details |
| A11809 | 30730350 | Am J Gastroenterol | Sex Hormone-Binding Globulin Levels in Young Men Are Associated With Nonalcoholic Fatty Liver Disease in Midlife. | 2019 | Details |
| A11810 | 30729549 | Hepatology | Reply. | 2019 | Details |
| A11811 | 30729382 | Curr Obes Rep | Obesity in South Asia: Phenotype, Morbidities, and Mitigation. | 2019 | Details |
| A11812 | 30727943 | BMC Biochem | Association of TM6SF2 rs58542926 gene polymorphism with the risk of non-alcoholic fatty liver disease and colorectal adenoma in Chinese Han population. | 2019 | Details |
| A11814 | 30724128 | Physiology (Bethesda) | Impact of Lipotoxicity on Tissue "Cross Talk" and Metabolic Regulation. | 2019 | Details |
| A11815 | 30724047 | Pak J Biol Sci | Preparation and Evaluation of Functional Foods for Prevention of Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A11816 | 30723896 | Lipids | Molecular Characterization of Microvesicular and Macrovesicular Steatosis Shows Widespread Differences in Metabolic Pathways. | 2019 | Details |
| A11818 | 30721572 | Liver Int | Randomized trial comparing effects of weight loss by liraglutide with lifestyle modification in non-alcoholic fatty liver disease. | 2019 | Details |
| A11819 | 30721562 | Liver Int | MicroRNA-30b regulates insulin sensitivity by targeting SERCA2b in non-alcoholic fatty liver disease. | 2019 | Details |
| A11820 | 30721255 | PLoS One | Correction: Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study. | 2019 | Details |
| A11821 | 30720827 | Food Funct | Monascus yellow, red and orange pigments from red yeast rice ameliorate lipid metabolic disorders and gut microbiota dysbiosis in Wistar rats fed on a high-fat diet. | 2019 | Details |
| A11822 | 30720188 | Eur Rev Med Pharmacol Sci | Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities. | 2019 | Details |
| A11823 | 30720104 | Mol Med Rep | Tetramethylpyrazine reduces inflammation in the livers of mice fed a high fat diet. | 2019 | Details |
| A11824 | 30720100 | Mol Med Rep | Comprehensive bioinformatics analysis of critical lncRNAs, mRNAs and miRNAs in non‑alcoholic fatty liver disease. | 2019 | Details |
| A11825 | 30720095 | Mol Med Rep | Comprehensive circular RNA expression profiles in a mouse model of nonalcoholic steatohepatitis. | 2019 | Details |
| A11826 | 30719457 | J Immunol Res | The Crosstalk between Fat Homeostasis and Liver Regional Immunity in NAFLD. | 2019 | Details |
| A11827 | 30719448 | Biomed Res Int | Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11828 | 30718741 | Sci Rep | Dietary Niacin Intake Predicts the Decrease of Liver Fat Content During a Lifestyle Intervention. | 2019 | Details |
| A11829 | 30717355 | Nutrients | Association between Sleep Disturbances and Liver Status in Obese Subjects with Nonalcoholic Fatty Liver Disease: A Comparison with Healthy Controls. | 2019 | Details |
| A11830 | 30717274 | Metabolites | The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD). | 2019 | Details |
| A11831 | 30717085 | Nutrients | Weight Gain and Liver Steatosis in Patients with Inflammatory Bowel Diseases. | 2019 | Details |
| A11832 | 30716793 | Hepatol Res | Clinical and pathological features of sarcopenia-related indices in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A11833 | 30716478 | Clin Gastroenterol Hepatol | Validation of a Model for Identification of Patients With Compensated Cirrhosis at High Risk of Decompensation. | 2019 | Details |
| A11834 | 30715741 | Hepatology | Glial Cell Line-Derived Neurotrophic Factor Enhances Autophagic Flux in Mouse and Rat Hepatocytes and Protects Against Palmitate Lipotoxicity. | 2019 | Details |
| A11835 | 30714632 | Aliment Pharmacol Ther | Review article: shared disease mechanisms between non-alcoholic fatty liver disease and metabolic syndrome - translating knowledge from systems biology to the bedside. | 2019 | Details |
| A11836 | 30713255 | Biol Pharm Bull | Preventive Effect of Citrus aurantium Peel Extract on High-Fat Diet-Induced Non-alcoholic Fatty Liver in Mice. | 2019 | Details |
| A11837 | 30712783 | Clin Nutr | ESPEN guideline on clinical nutrition in liver disease. | 2019 | Details |
| A11838 | 30712318 | Liver Int | Ideal cardiovascular health metrics and the risk of non-alcoholic fatty liver disease: A cross-sectional study in northern China. | 2019 | Details |
| A11839 | 30711707 | Toxicology | The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice. | 2019 | Details |
| A11840 | 30711569 | Metabolism | LncRNA MEG3 functions as a ceRNA in regulating hepatic lipogenesis by competitively binding to miR-21 with LRP6. | 2019 | Details |
| A11841 | 30711404 | J Hepatol | Autophagy in liver diseases: Time for translation? | 2019 | Details |
| A11842 | 30711302 | Rev Gastroenterol Mex (Engl Ed) | The Mexican consensus on nonalcoholic fatty liver disease. | 2019 | Details |
| A11843 | 30711017 | Lipids Health Dis | Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study. | 2019 | Details |
| A11844 | 30710884 | Nutrition | No association between fruits or vegetables and non-alcoholic fatty liver disease in middle-aged men and women. | 2018 | Details |
| A11845 | 30710743 | J Steroid Biochem Mol Biol | Mitochondrial oxysterol biosynthetic pathway gives evidence for CYP7B1 as controller of regulatory oxysterols. | 2019 | Details |
| A11846 | 30710115 | Pediatr Res | Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesity. | 2019 | Details |
| A11847 | 30708325 | Redox Biol | Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy. | 2019 | Details |
| A11848 | 30708259 | Nutrition | Dietary patterns and non-alcoholic fatty liver disease in a Greek case-control study. | 2018 | Details |
| A11849 | 30708111 | Clin Gastroenterol Hepatol | Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis. | 2019 | Details |
| A11850 | 30708110 | Clin Gastroenterol Hepatol | Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide. | 2019 | Details |
| A11851 | 30708109 | Clin Gastroenterol Hepatol | Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices. | 2019 | Details |
| A11852 | 30708071 | Diabetes Metab | Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: A common comorbidity associated with severe complications. | 2019 | Details |
| A11853 | 30708053 | Nanomedicine | Zinc oxide nanoparticles attenuate hepatic steatosis development in high-fat-diet fed mice through activated AMPK signaling axis. | 2019 | Details |
| A11854 | 30707422 | J Robot Surg | The impact of body mass index on perioperative outcomes after robotic liver resection. | 2019 | Details |
| A11855 | 30707282 | J Gastroenterol | Serum aldo-keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis. | 2019 | Details |
| A11856 | 30707092 | Nutr Res Rev | Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases. | 2019 | Details |
| A11857 | 30706694 | J Dig Dis | Role of gut microbial metabolites in nonalcoholic fatty liver disease. | 2019 | Details |
| A11858 | 30706504 | Hepatology | Association Between Nonalcoholic Fatty Liver Disease and Reduced Bone Mineral Density in Children: A Meta-Analysis. | 2019 | Details |
| A11859 | 30706422 | Drugs | L-Ornithine L-Aspartate (LOLA) as a Novel Approach for Therapy of Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A11860 | 30705893 | World J Clin Cases | Interventions to improve sarcopenia in cirrhosis: A systematic review. | 2019 | Details |
| A11861 | 30705715 | World J Hepatol | Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. | 2019 | Details |
| A11862 | 30705687 | Nutr Metab (Lond) | Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial. | 2019 | Details |
| A11863 | 30705499 | Clin Diabetes | Patients With Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality. | 2019 | Details |
| A11864 | 30705240 | BMJ Open | Fatty liver disease and the risk of erosive oesophagitis in the Korean population: a cross-sectional study. | 2019 | Details |
| A11865 | 30704899 | Mol Cell | Pacer Is a Mediator of mTORC1 and GSK3-TIP60 Signaling in Regulation of Autophagosome Maturation and Lipid Metabolism. | 2019 | Details |
| A11866 | 30703849 | Hepatology | F-box/WD Repeat-Containing Protein 5 Mediates the Ubiquitination of Apoptosis Signal-Regulating Kinase 1 and Exacerbates Nonalcoholic Steatohepatitis in Mice. | 2019 | Details |
| A11867 | 30703836 | Dtsch Med Wochenschr | [The Diabetic Heart and Heart Failure - Update on Mechanisms and Therapy]. | 2019 | Details |
| A11868 | 30703747 | J Inorg Biochem | Liver pathology in Wilson's disease: From copper overload to cirrhosis. | 2019 | Details |
| A11869 | 30703416 | Pharmacol Ther | Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders. | 2019 | Details |
| A11870 | 30702924 | Appl Physiol Nutr Metab | Sex-based differences in hepatic and skeletal muscle triglyceride storage and metabolism 1. | 2019 | Details |
| A11871 | 30701940 | Ter Arkh | The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease. | 2018 | Details |
| A11872 | 30701781 | Ter Arkh | Optimizing therapy of liver diseases not associated with viral infection. | 2018 | Details |
| A11873 | 30701779 | Ter Arkh | Clinical-morphological parallels of the PNPLA3 gene polymorphism in patients with nonalcoholic fatty liver disease. | 2018 | Details |
| A11874 | 30701776 | Ter Arkh | Intrahepatic cholestasis in nonalcoholic fatty liver disease. | 2018 | Details |
| A11875 | 30701611 | J Magn Reson Imaging | Pilot study on longitudinal change in pancreatic proton density fat fraction during a weight-loss surgery program in adults with obesity. | 2019 | Details |
| A11876 | 30700946 | World J Gastroenterol | Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease. | 2019 | Details |
| A11877 | 30700851 | Lab Invest | Impaired mitophagy triggers NLRP3 inflammasome activation during the progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis. | 2019 | Details |
| A11878 | 30700810 | Sci Rep | Depletion of B cell-activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease. | 2019 | Details |
| A11879 | 30700500 | Biochem Soc Trans | Dissecting metabolism using zebrafish models of disease. | 2019 | Details |
| A11881 | 34267963 | Florence Nightingale Hemsire Derg | [Is There an Effect of Dietary Fructose on Development and Prognosis of Chronic Diseases?] | 2019 | Details |
| A11882 | 30697898 | Liver Int | The interaction of nonalcoholic fatty liver disease and smoking on mortality among adults in the United States. | 2019 | Details |